The Role of F-18 FLT PET/CT for Selecting the Patients Who Need Maintenance Treatment After First-line Chemotherapy in Advanced Non-small Cell Lung Cancers
Sponsor study identifier
Secondary identifiers
OTHER · Seoul St.Mary's Hospital Institutional Review Board
observational
15
1 country
1
Study Start
June 2012
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
August 2013
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
August 2015
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The objective of this pilot study is to determine whether 18F-FLT PET/CT can predict which patients will have poorer progression free survival and overall survival in advanced Non-small Cell Lung Cancer (NSCLC) after first-line therapy and, therefore, need more aggressive treatment.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
August 2015
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 24, 2012
Actual (reported)June 2012
Date type not reportedThis date has not been verified as actual or estimated.
June 14, 2012
Actual (reported)August 2013
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
August 2015
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
overall survival
from the date of FLT PET/CT to the date of death or last follow-up, assessed up to 1 year
time to progression
from the date of FLT PET/CT to the date of documented progression or last follow-up, assessed up to 1 year
F-18 FLT PET/CT
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
advanced non-small cell lung cancer
Seoul St.Mary's Hospital
Seoul, 137-701, South Korea
Ie Ryung Yoo, MD
Seoul St. Mary's Hospital
Jin Hyoung Kang, MD, PhD
Seoul St. Mary's Hospital
First Submitted
May 24, 2012
First Posted
June 14, 2012
Study Start
June 2012
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
August 2013
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
August 2015
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
June 14, 2012
Record last verified: 2012-06
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: